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Abstract: MicroRNAs (miRNAs) regulate cartilage differentiation and contribute to the onset and
progression of joint degeneration. These small RNA molecules may affect extracellular matrix
organization (ECM) in cartilage, but for only a few miRNAs has this role been defined in vivo.
Previously, we showed that cartilage-specific genetic ablation of the Mirc24 cluster in mice leads
to impaired cartilage development due to increased RAF/MEK/ERK pathway activation. Here,
we studied the expression of the cluster in cartilage by LacZ reporter gene assays and determined
its role for extracellular matrix homeostasis by proteome and immunoblot analysis. The cluster is
expressed in prehypertrophic/hypertrophic chondrocytes of the growth plate and we now show
that the cluster is also highly expressed in articular cartilage. Cartilage-specific loss of the cluster
leads to increased proteoglycan 4 and matrix metallopeptidase 13 levels and decreased aggrecan
and collagen X levels in epiphyseal cartilage. Interestingly, these changes are linked to a decrease in
SRY-related HMG box-containing (SOX) transcription factors 6 and 9, which regulate ECM production
in chondrocytes. Our data suggests that the Mirc24 cluster is important for ECM homoeostasis and
the expression of transcriptional regulators of matrix production in cartilage.
Keywords: extracellular matrix; Mirc24; miR-322; miR-503; cartilage; PRG4; articular; SOX9;
SOX6; MMP13
1. Introduction
MicroRNAs (miRNAs) are promising targets to control cartilage degeneration and promote
its repair. These small single-stranded RNAs can bind to multiple mRNA targets to regulate the
activity of entire signalling pathways and cellular responses and may therefore also contribute to
cartilage homeostasis. Numerous miRNAs were shown to be associated with osteoarthritis (OA)
pathology and computational approaches predict complex interactions with gene signalling networks
to mediate cartilage-protective or destructive effects [1,2], but for few miRNAs the biological relevance
was demonstrated.
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MiR-140 was among the first miRNAs described to be expressed in cartilage and to be
downregulated in human OA. The genetic ablation of this miRNA caused a short stature and
age-related OA-like phenotype with proteoglycan loss due to elevated ADAMTS5 expression and
fibrillation of articular cartilage. The overexpression of miR-140 in cartilage prevented antigen-induced
arthritis in transgenic mice [3], further supporting a key role for this miR in cartilage homeostasis.
Proteoglycans are highly hydrated macromolecules of the extracellular matrix (ECM) that confer the
compression strength to cartilage [4] and miR-140 may protect this network from ADAMTS5-mediated
degradation. Therefore, miRNAs can prevent ECM destruction in cartilage in vivo, but may also
regulate ECM protein production. Previously, we showed that miR-26a is increasingly expressed in
growth plate cartilage to suppress the expression of the ECM adaptor proteins COMP and matrilin-3
in chondrocytes [5], resulting in destabilization of the interaction between the collagen containing
fibrillar and the proteoglycan enriched extrafibrillar ECM compartment. We also demonstrated that the
cartilage specific genetic ablation of the Mirc24 cluster in mice (Col2a1-Cre-Mirc24tm1M mice), which
encodes for the miRNAs miR-322, miR-351 and miR-503, leads to impaired cartilage development with
fatal consequences. The expression of this cluster is upregulated during chondrocyte differentiation
and loss of the Mirc24 cluster encoded miR-322 leads to increased RAF/MEK/ERK pathway activation
and reduced cartilage growth [6]. The miR-322 was described to target Igf1r and Insr upstream of the
RAF/MEK/ERK pathway in skeletal muscle [7] and vascular smooth muscle cells [8] and to interact with
the epigenetic modifier SETD3 to regulate skeletal muscle differentiation [9]. Interestingly, miR-322
stabilizes Mek1 mRNA to increase MEK1 protein levels and inhibit the activation of the RAF/MEK/ERK
pathway in cartilage, but does not regulate IGF1R and INSR levels [6]. Therefore, target specificity of
miR-322 may vary between cell types. MiR-351 binds to the mRNA of the vitamin D receptor to inhibit
its expression and to modulate osteoblast-mediated bone formation [10] and fibrosis [11], whereas
miR-503 targets Smurf1 to modulate TGF-β signaling and promotes osteogenesis [12]. Hence, Mirc24
cluster encoded miRNAs are important epigenetic factors controlling musculoskeletal development
and these miRNAs may also regulate ECM homeostasis in cartilage. [12]
Here, we examined the expression of the Mirc24 cluster in articular cartilage and analyzed the
composition of the cartilage ECM in mice where the cluster was conditionally ablated in cartilage
(Col2a1-Mirc24tm1M) to determine its biological relevance for ECM organization.
2. Results
2.1. The Mirc24 Cluster Is Expressed in Articular Cartilage and Downregulated in Experimental OA
To study the expression of the Mirc24 cluster encoded miRNAs in developing cartilage in detail we
detected the LacZ reporter gene expression in Mirc24-LacZ+ transgenic mice using X-Gal staining on
whole mounts of the distal epiphysis of the femur and on sections through joints. The blue X-Gal staining
product was detected in the chondrocytes of epiphyseal cartilage (Figure 1a,b asterix) and the staining
intensity was increased in the superficial zone of articular cartilage (Figure 1b, arrowheads). Previously,
we demonstrated that the cluster is also expressed in differentiating prehypertrophic/hypertrophic
chondrocytes [6]. The results indicate that cluster expression is associated with late chondrocyte
differentiation in growth plate and articular cartilage.
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Figure 1. Characterization of the Mirc24 cluster expression in epiphyseal cartilage. Expression of the 
LacZ reporter gene in (a) isolated femora of Mirc24X/X and Mirc24tm1M/X female newborns and (b) 
sections of the distal epiphyseal femoral joints of Col2a1-Cre (Cre) and Col2a1-Cre-Mirc24 tm1M/Y (hKO) 
newborn males was detected by X-Gal staining and assessed by microscopy. Asterix: epihyseal head 
cartilage, arrowheads: articular cartilage, bar: (a,b) 200 µm. (c) Expression of the Mirc24 cluster-
encoded miR-322-5p in articular cartilage from mice subjected to sham or destabilization of the medial 
meniscus (DMM) surgery (n = 3) at 1 and 6 weeks was determined by Geo2R analysis and expression 
intensity and p-value of the GEO dataset GSE93008 are shown. 
To detect Mirc24 cluster encoded miRNAs in intact and damaged mature articular cartilage, we 
analyzed the expression of the cluster-encoded miRNAs miR-322, miR-351 and miR-503 using the 
expression dataset (GEO DataSet GSE93008) of a mouse model with post-traumatic osteoarthritis 
(OA) [13]. In this study, expression profiles of miRNAs were determined in medial tibial cartilage 
from sham or DMM (destabilization of the medial meniscus) operated 10–12-week-old male wild-
type C57BL/6 mice. Here, the cluster-encoded miR-322 was detected in the intact cartilage of sham-
operated joints at 1 week and 6 weeks and its expression was slightly reduced in cartilage of DMM-
operated joints at both time points (Figure 1c). MiR-351 and miR-503 were not detected. Hence, the 
cluster is expressed also in mature articular cartilage, miR-322 is the predominately expressed 
miRNA of the cluster and its expression is altered in DMM. 
Figure 1. Characterization of the Mirc24 cluster expression in epiphyseal cartilage. Expression of
the LacZ reporter gene in (a) isolated femora of Mirc24X/X and Mirc24tm1M/X female newborns and
(b) sections of the distal epiphyseal femoral joints of Col2a1-Cre (Cre) and Col2a1-Cre-Mirc24 tm1M/Y
(hKO) newborn males was detected by X-Gal staining and assessed by microscopy. Asterix: epihyseal
head cartilage, arrowheads: articular cartilage, bar: (a,b) 200 µm. (c) Expression of the Mirc24
cluster-encoded miR-322-5p in articular cartilage from mice subjected to sham or destabilization of
the medial meniscus (DMM) surgery (n = 3) at 1 and 6 weeks was determined by Geo2R analysis and
expression intensity and p-value of the GEO dataset GSE93008 are shown.
o cl ster encoded miRNAs in intact an damaged mature articular cartilage,
we analyzed the expressi n of the cluster-encoded miRNAs miR-322, miR-351 and miR-503 using
the expression dataset (GEO DataSet GSE93008) of a mouse model ith t iti
( ) [13]. , e i r fil f i ere deter i i e i l ti ial cartil
fr sham or DMM (destabilization of the medial meniscu ) operated 10– 2-week-old male wild-type
C57BL/6 mice. Her , th clust r-encoded miR-322 was detecte in th intact cartil ge of sh m- perated
j ints at 1 week nd 6 weeks and its expression was lightly reduced in cartilage of DMM- perated
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joints at both time points (Figure 1c). MiR-351 and miR-503 were not detected. Hence, the cluster is
expressed also in mature articular cartilage, miR-322 is the predominately expressed miRNA of the
cluster and its expression is altered in DMM.
2.2. ECM Entities Are Enriched in Proteome Analysis of Mirc24 Cluster-Deficient Epiphyseal Cartilage Extracts
We hypothesized that the cluster regulates ECM homeostasis in cartilage and therefore studied
the ECM composition in mice with cartilage-specific genetic ablation of the Mirc24 cluster. To define
changes in protein abundance we first isolated femoral and tibial epiphyses of Col2a1-Cre (Cre) and
Col2a1-Cre-Mirc24tm1M/Y (hemizygous, hKO) newborns and subjected the samples to proteome analysis
using established protocols [14]. Samples of five biological replicates were deglycosylated followed by
extraction with 4 M GuHCl to isolate ECM molecules from epiphyses. After trypsin digest samples
were assayed by mass spectrometry and the generated data set was analyzed using MaxQuant and
Perseus software. Principal component analysis shows that data sets were substantially different
between genotypes. Extracts from Col2a1-Cre-Mirc24tm1M/Y cartilage separate well from extracts from
Col2a1-Cre cartilage (Figure 2a). In total 2260 proteins were identified in epiphyseal cartilage and
among those 93 were differentially abundant between femoral epiphyseal cartilage extracts from
Col2a1-Cre and Col2a1-Cre-Mirc24tm1M/Y mice, respectively (Q < 0.05 sO 0.2) (Figure 2b, Supplemental
Table S1)). Hierarchical cluster analysis determined a cluster of 31 proteins with decreased abundance
and a cluster of 62 proteins with increased abundance in cartilage from Col2a1-Cre-Mirc24tm1M/Y mice
(Figure 2c). Most proteins showed changes of ~2-fold in protein abundance with several others that
were more strongly decreased or increased. Interestingly, among the more highly regulated proteins
the ECM proteoglycan 4 (PRG4—synonyms lubricin, superficial zone protein) showed a 5-fold increase
in cartilage extracts of Col2a1-Cre-Mirc24tm1M/Y mice (Figure 3a). Next, we used string-implemented
reactome pathway enrichment analysis [15,16]. While no enriched pathways were detected for the
cluster with decreased protein abundance, 10 enriched pathways were found for the cluster with
increased abundance. Pathways involved in mRNA-cleavage (1.), -processing and –splicing (2.–4.)
were significant and extracellular matrix organization (5.) was among the highest ranked pathways
(Figure 3b). Based on this, a full analysis of the detected matrisome [17,18] was used to determine ECM
constituents with changed abundance in cartilage extracts of Col2a1-Cre-Mirc24tm1M/Y mice. In total
six matrisome proteins were identified as altered, including three proteins of the core matrisome
(PRG4, bone sialoprotein 2 (IBSP), vitronectin (VTN) and three proteins of the matrisome-associated
data set (matrix metallopeptidase 13 (MMP13), peptidase domain containing associated with muscle
regeneration 1 (PAMR1) and midkine (MDK) (Figure 3c).
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Figure 2. Proteome analysis of epiphyseal cartilage from Mirc24 deficient mice. (a) Principal 
component analysis of the proteome dataset. Each circle represents an individual sample of 
epiphyseal cartilage isolated from Col2a1-Cre (Cre) or Col2a1-Cre-Mirc24tm1M/Y (hKO) newborn mice. 
(b) Volcano plot illustrating significant changes within the dataset. Proteins with the highest fold 
change are marked (blue). (c) Non-averaged hierarchical clustered intensity plot (distant metrics—
euclidean, linkage rule—complete) of differentially abundant proteins. Protein symbols within the 
clusters are given and the relative protein abundance is indicated (blue—low, red—high). Proteins 
with the highest fold change are marked (blue) (arrowheads). 
Figure 2. Proteome analysis of epiphyseal cartilage from Mirc24 deficient mice. (a) Principal component
analysis of the proteome dataset. Each circle represents an individual sample of epiphyseal cartilage
isolated from Col2a1-Cre (Cre) or Col2a1-Cre-Mirc24tm1M/Y (hKO) newborn mice. (b) Volcano plot
illustrating significant changes within the dataset. Proteins with the highest fold change are marked
(blue). (c) Non-averaged hierarchical clustered intensity plot (distant metrics—eucli ean, linkage
rule—complete) of differentially abundant prot ins. Protei symbols within th clusters are give
and the r lativ protein abundance is indicated ( l e—low, red—high). Prot ins with the highest fold
change are marked (blue) (arrowheads).
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Figure 3. Identification of regulated protein interaction networks in cartilage extracts from Mirc24 
deficient mice. (a) Proteins with decreased (dw in hKO, left) and increased (up in hKO, right) intensity 
are ranked according to the fold change. The results of the (b) reactome pathway characterization of 
increased proteins within string database and the (c) matrisome analysis of regulated entities are 
shown. 
2.3. ECM Composition and SOX 6/9 Expression Is Altered in Mirc24-Cluster Deficient Epiphyseal Cartilage 
To validate the results of the proteome analysis cartilage extracts were also analyzed by 
immunoblotting using antibodies against PRG4 and IBSP. PRG4 is a highly glycosylated protein with 
different isoforms [19] and we could detect increased levels of presumably monomeric proteins at an 
apparent molecular weight above 250 kDa in Mirc24 mice (Figure 4a). No changes in IBSP protein 
levels in cartilage extracts of Col2a1-Cre-Mirc24tm1M/Y mice were detected when compared with 
extracts of Col2a1-Cre mice. MMP13 expression was studied by immunofluorescence analysis using 
sections of the femoral growth plate of Col2Cre and Col2a1-Cre-Mirc24 tm1M/Y mice. Here a significant 
increase in signal intensity in late hypertrophic growth plate cartilage and the bone marrow of 
Col2a1-Cre-Mirc24 tm1M/Y mice was observed (Figure 4b and Supplemental Figure S2a). In situ 
zymography indicated that gelatinase activity was increased at these sites of MMP13 expression in 
cartilage and bone (Figure 4b and Supplemental Figure S2b) and in-gel zymography showed for the 
latent and active MMP13 that clear bands against a blue background of undigested substrate were 
detected in femoral extracts of Col2Cre and Col2a1-Cre-Mirc24 tm1M/Y mice. The activity of the latent 
form was increased in Col2a1-Cre-Mirc24 tm1M/Y newborn mice compared to control (Figure 4c, 
quantification). 
Figure 3. Identification of regulated protein interaction networks in cartilage extracts from Mirc24
deficient mice. (a) Proteins with decreased (dw in hKO, left) and increased (up in hKO, right) intensity
are ranked according to the fold change. The results of the (b) reactome pathway characterization of
increased proteins within string database and the (c) matrisome analysis of regulated entities are shown.
2.3. ECM Composition and SOX 6/9 Expression Is Altered in Mirc24-Cluster Deficient Epiphyseal Cartilage
To validate the results of the proteome analysis cartilage extracts were also analyzed by
immunoblotting using antibodies against PRG4 and IBSP. PRG4 is a highly glycosyl ted protein
with differen isoforms [19] an we could detect increased levels of presumabl monomeric proteins at
an apparent molecular weight above 250 kDa in Mirc24 mice (Figure 4 ). No chang s in IBSP pro ei
levels i cartilage extracts of Col2a1-Cre-Mirc24tm1M/Y mice were det cted when compared with extracts
of Col2a1-Cre mic . MMP13 expression was studied by immunofluorescenc analysis using sections of
the femoral growth plate of Col2Cre and Col2a1-Cre-Mirc24 tm1M/Y mice. Here a ig ific t increase in
ignal intensity in late hypertro hic growth plate cartilage and the bone marrow of Col2a1-Cre-Mirc24
tm1M/Y mice was observed (Figure 4b and Supplemental Figure S2a). In situ zymography indic ted that
gelatinase activity was increased at these sit s of MMP13 expression in cartilage and bone (Figure 4b
and Suppleme tal Figure S2b) and in-gel zymogr phy showed for th lat nt and active MMP13 that
lear bands against a blue backgro nd of u digested su strate wer detected in fem ral extracts
of Col2Cre and Col2a1-Cre-Mirc24 tm1M/Y mice. The activity of the latent form was inc eased in
Col2a1-Cre-Mirc24 tm1M/Y newborn mice compared to control (Figure 4c, quantifica on).
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Figure 4. Characterization of PRG4, IBSP and MMP13 levels in femoral joint cartilage. (a) PRG4 and 
IBSP protein levels were determined in newborn cartilage extracts from Col2a1-Cre (Cre) and Col2a1-
Cre-Mirc24tm1M/Y (hKO) mice using immunoblots. GAPDH was used as loading control. Quantification 
is shown (graph, PRG4 n = 3, IBSP n = 6). GAPDH‡ indicates that PRG4, SOX6 and SOX9 were tested 
on a single blot and the same GAPDH blot is shown in Figure 4a and Figure 5c. Additional 
immunoblots are shown in Supplemental Figure S3a. (b) MMP13 localization was studied by 
immunofluorescence analysis (DAPI—blue, MMP13—green, pseudocolored) and gelatinase activity 
was determined by in situ zymography in newborn femoral epiphysis. Brightness was adjusted for 
visualization. (c) MMP13 activity in femoral extracts was analyzed by gelatin zymography. Latent 
proMMP13 and active MMP13 are indicated. GAPDH was used as loading control. Fold change of 
total, latent and active MMP13 in hKO extracts compared to Cre was determined (graph, n = 3). 
Molecular weights of Thermo Scientific™ PageRuler™ Plus Prestained 10–250 kDa Protein Ladder 
bands are given. Scale bar 100 µm. p < 0.05(*). 
Figure 4. Charact rization of PRG4, IBSP and MM 13 levels in femoral joint cartilage. (a) PRG4
and IBSP protein levels w r det mined in ewborn cartilage extracts from C l2a1-Cre ( ) and
Col2a1-Cre-Mirc24tm1M /Y (hKO) mice using im unoblots. as used as loading control.
Quantification is shown (graph, PRG4 n = 3, IBSP n = 6). GAPDH‡ indicates that PRG4, SOX6
and SOX9 were te ted on a single blot and the same GAPDH blot is shown in Figures 4a and .
Additional im unoblots are shown i Supplemental Figure S3a. (b) MMP13 localization w s studied
by immunofluorescence analysis (DAPI—blue, MMP13—green, pseudocolored) and gelatinase activity
was determined by in situ zymography in newborn femoral epiphysis. Brightne s was adjusted for
visualization. (c) MMP13 a tivity in femoral extracts w s analyzed by gelatin zymo raphy. Latent
proMMP13 and active MMP13 are indicated. GAPDH was used as loading control. F l change of total,
latent and ac ive MMP13 i hKO extracts compared to Cre was determined (graph, n = 3). Molecular
weights of Thermo Scientific™ PageRuler™ Plus Prestained 10–250 kDa rotei Ladder bands are
given. Scale r 100 µm. p < 0.05 (*).
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Figure 5. Analysis of the ECM and SOX protein expression in cartilage. Cartilage extracts from 
Col2a1-Cre (Cre) and Col2a1-Cre-Mirc24tm1M/Y (hKO) mice were analyzed for the presence of (a) 
collagen II, (b) collagen IX, aggrecan, and X as well as (c) SOX6 and SOX9 using immunoblots. 
GAPDH was used as loading control. GAPDH* indicates that Collagen II and X were tested on a 
single blot and the same GAPDH blot is shown in (a) and (b). GAPDH‡ indicates that PRG4, SOX6 
and SOX9 were tested on a single blot and the same GAPDH blot is shown in Figure 4a and Figure 
5c. Quantification is shown (graph, n ≥ 6). Additional immunoblots are shown in Supplemental Figure 
S3b–d. Molecular weights of Thermo Scientific™ PageRuler™ Plus Prestained 10–250 kDa Protein 
Ladder bands are given. p < 0.05(*), p < 0.01(**). 
To further expand the characterization of the extracellular matrix and identify changes that were 
maybe not detected by proteome analysis, the abundance of fibrillar and extrafibrillar ECM were 
characterized in immunoblots (Figure 5 and Supplemental Figure S3). The abundance of the fibrillar 
collagen II and the adaptor protein collagen IX was not significantly altered, whereas levels of the 
extrafibrillar proteoglycan aggrecan and the network forming collagen X were significantly reduced 
in cartilage extracts from Col2a1-Cre-Mirc24tm1M mice. The results show that these components of the 
cartilage ECM are decreased in cartilage extracts of Col2a1-Cre-Mirc24 tm1M/Y mice. ECM production 
in cartilage is controlled by SRY-related HMG box-containing (SOX) transcription factors and we also 
determined protein levels of the key transcription factor regulating ECM production, SOX9, and its 
cofactor SOX6 using immunoblots. Total levels of both transcription factors were strongly decreased 
in cartilage extracts of Col2a1-Cre-Mirc24tm1M/Y mice. Hence, loss of the cluster Mirc24 cluster in 
cartilage reduces the expression of key transcriptional regulators in ECM formation. 
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(Cre) and Col2a1-Cre-Mirc24tm1M/Y (hKO) mice w re analyzed for the presence of (a) collagen
II, (b) collagen IX, ag recan nd X s well as (c) SOX6 nd SOX9 using immunoblots. GAPDH was
used as loading control. GAPDH* indicates that Collagen II nd X were teste on a single blot and
the same GAPDH blot is shown in (a) and (b). GAPDH‡ indicates that PRG4, SOX6 and SOX9 were
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To further expand the characterization of the extracellular atrix and identify changes that ere
aybe not detected by proteo e analysis, the abundance of fibrillar and extrafibrillar EC ere
characterized in i unoblots (Figure 5 and Supple ental Figure S3). The abundance of the fibrillar
collagen II and the adaptor protein collagen IX as not significantly altered, hereas levels of the
extrafibrillar proteoglycan aggrecan and the network forming collagen X were significantly reduced in
cartilage extracts from Col2a1-Cre-Mirc24tm1M mice. The results sho that these co ponents of the
cartilage EC are decreased in cartilage extracts of Col2a1-Cre-Mirc24 tm1M/Y ice. EC production
in cartilage is controlled by SRY-related box-containing (S X) transcription factors and e also
deter ined protein levels of the key transcription factor regulating EC production, S X9, and its
cofactor S X6 using i unoblots. Total levels of both transcription factors were strongly decreased in
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cartilage extracts of Col2a1-Cre-Mirc24tm1M/Y mice. Hence, loss of the cluster Mirc24 cluster in cartilage
reduces the expression of key transcriptional regulators in ECM formation.
3. Discussion
Despite the extensive knowledge of genetic factors controlling ECM/cartilage formation, maintenance
and repair, the role of epigenetic factors in vivo has yet to be determined. Here, we studied the
consequences of the Mirc24 cluster deficiency for ECM homeostasis in cartilage and show that this cluster
is important for ECM organization.
Previously, we identified expression of the Mirc24 cluster in prehypertrophic/hypertrophic growth
plate cartilage [6] and we now demonstrate that the cluster is also highly expressed in articular
cartilage. Hence, cluster expression is closely linked to chondrocyte differentiation. The cluster encodes
several miRNAs, but among the cluster-encoded miRNAs only miR-322 and miR-503 are expressed in
prehypertrophic/hypertrophic growth plate cartilage and only miR-322 is expressed in mature articular
cartilage in 10–12 week old male WT C57BL/6. Here, aging and genetic background may contribute to
the differential expression of cluster-encoded miRNAs. The observed effects on ECM organization in
cartilage of Mirc24 deficient mice could be attributed to the loss of the two cluster-encoded miRNAs
miR-322 and miR-503 in epiphyseal cartilage. Furthermore, the reduced levels of miR-322 in the
lesional cartilage from mice where OA is induced by meniscal destabilization, and correspondingly
reduced miR-322 and miR-503 in the OA subchondral bone [13] may implicate these components of
the Mirc24 cluster in cartilage homeostasis and degeneration.
We hypothesized that cluster-encoded miRNAs are likely to regulate ECM production in
differentiated chondrocytes and this was supported by reactome pathway analysis of the proteome
dataset. Interestingly, of the components belonging to the significant pathway “ECM organization”
that were altered in Col2a1-Cre-Mirc24 tm1M/Y mice, none are predicted targets of the cluster-encoded
miRNAs [20]. In addition, the majority of the cluster-encoded miRNAs inhibit expression of their
respective target genes. Therefore, the observed increase in these ECM components is presumably
secondary to the changes in target gene expression. The proteoglycan PRG4 showed the strongest
increase (Figure 3a, ~5-fold) among the ECM proteins in cartilage extracts from Col2a1-Cre-Mirc24
tm1M/Y mice. This protein is extensively glycosylated with attachment sites for chondroitin and keratan
sulfate chains and with the capability to from multimers [19]. We confirmed by immunoblot an increase
in the levels of monomeric species of the appropriate molecular size but this was not accompanied by
changes in Prg4 mRNA expression (see Supplemental Figure S1) in chondrocytes of Col2a1-Cre-Mirc24
tm1M/Y mice. Therefore, we hypothesize that cluster encoded miRNAs affect post-translational PRG4
modification that might alter protein stability or deposition within the articular cartilage matrix.
The cluster may also be important for ECM degradation. MMP13 protein levels were significantly
increased in proteome analysis and by immunofluorescence we observed an increased MMP13 signal
intensity at the chondroosseus border and the bone marrow of Col2a1-Cre-Mirc24 tm1M/Y mice compared
to control, as well as increased gelatinase activity at the sites of MMP13 expression. Several cartilage
ECM substrates are degraded by MMP13 and among those collagen II, aggrecan and collagen X
are targeted by MMP13 to remodel the ECM and promote cartilage to bone transformation [21,22].
We observed a reduction of collagen X and aggrecan by immunoblot and this could be linked to
increased MMP13-mediated degradation of these ECM molecules at the chondroosseus junction of
Col2a1-Cre-Mirc24 tm1M/Y mice. The decrease in collagen X is also in line with our previous results,
where a significant decrease in collagen X-positive hypertrophic zone was seen in immunostainings of
the chondroosseous junction of Col2a1-Cre-Mirc24 tm1M/Y mice [6]. Conversely, no decrease in collagen
II levels was detected, but the mature collagen fibrils of the cartilage ECM may be less susceptible to
early cleavage events due to the presence of numerous adaptor proteins and other small proteoglycans.
While collagen II protein levels were similar between Col2a1-Cre-Mirc24 tm1M/Y mice compared to
control, the transcription factors SOX9 and SOX6 were reduced. These changes were not apparent
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in the proteome analysis but differences in detection may be due to technical differences in sample
treatment and sensitivity between immunoblot and proteome analysis [23].
We observed a decrease of SOX6 and SOX9 protein levels in epiphyseal cartilage of
Col2a1-Cre-Mirc24 tm1M/Y mice by immunoblot and these proteins are essential transcriptional regulators
of cartilage differentiation and ECM production. SOX9 is required for chondrocyte proliferation and
hypertrophy and the decrease in SOX9 levels may contribute to the significant decrease in the total
area of hypertrophic cells in femora of Col2a1-Cre-Mirc24 tm1M/Y mice [6]. SOX9 also regulates the
expression of its own partners in transcriptional regulation, SOX6 and SOX5 [24] and the SOX trio act
in concert to transactivate cartilage matrix genes including those encoding aggrecan [25] and collagen
X [26]. Hence, the decrease in SOX9 and SOX6 may directly inhibit ECM production and therefore
affect the stability of the cartilage ECM in Col2a1-Cre-Mirc24 tm1M/Y mice.
miRNAs are often seen as potential therapeutic opportunity for OA and other cartilage degenerative
diseases, but regulation by miRNAs is complex and may include cartilage-protective and destructive
mechanisms and signaling pathways [1] adding another level of complexity to the posttranscriptional
regulation of cartilage development and homeostasis. In this study we show that miRNAs of the
Mirc24 cluster, in particular miR322, which is dysregulated in mouse OA cartilage, has a potentially
important role in cartilage ECM protective and destructive processes in vivo.
4. Materials and Methods
4.1. Mice
MicroRNA cluster 24 transgenic mice (Mirc24tm1M/tm1M), containing a LacZ reporter gene and lox
sites to inactivate the cluster-encoded miR-322, miR-351 and miR-503 [27] and Col2a1-Cre mice [28] were
used for animal studies. Breeding protocols to generate hemizygous males Col2a1-Cre-Mirc24tm1M/Y
and Col2a1-Cre littermates were previously described [6]. All animal experiments were performed
in accordance with the animal ethics guidelines of the German animal protection law. Institutional
review board - Landesamt für Natur, Umwelt und Verbraucherschutz Nordrhein-Westfalen.
4.2. In Situ Detection of LacZ Reporter Gene Activity
Isolated femora from newborn mice were fixed for 15 min in 0.2% glutaraldehyde, 5 mM EGTA,
2 mM MgCl2, 0.1 M phosphate buffer, pH 7.3, washed three times with 2 mM MgCl2, 0.02% NP-40,
0.1 M phosphate buffer, pH 7.3 and stained in 50 mg/mL X-gal, 1 mM potassium ferricyanide,
2 mM MgCl2, 0.02% NP-40, 0.1 M phosphate buffer, pH 7.3 overnight at room temperature. Whole
mount stainings were assessed by microscopy. In addition, isolated femora were embedded in O.C.T.
Tissue-Tek (Sakura Finetek, Tokyo, Japan), sectioned using a Leica Cryotome CM3050. Sections (7 µm)
were incubated for 15 min in fixative and then stained for 16 h at RT and 10 h at 37 ◦C in X-Gal
staining solution. Sections were washed in 70% (v/v) ethanol and dH2O, mounted in Mowiol®® 4-88
(Sigma-Aldrich, St. Louis, MI, USA) and analyzed by microscopy (Nikon Eclipse TE2000-U Microscope,
Nikon, Tokyo, Japan).
4.3. miRNA Expression Analysis in the GEO Dataset GSE93008
The GEO dataset GSE93008 was originally generated by inducing osteoarthritis in adult male
C57BL6 mice using the destabilization of the medial meniscus (DMM) [13]. RNA from medial tibial
cartilage after sham or DMM surgery was isolated by dissection at 1 and 6 weeks after injury (n = 3/time
point/group) and the expression was studied using Agilent microarrays [13]. GEO2R analysis tool
(https://www.ncbi.nlm.nih.gov/geo/geo2r) was used to compare sham and DMM samples and to
identify differentially expressed miRNAs of the Mirc24 cluster.
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4.4. Protein Extraction
Femoral and tibia knee cartilage from newborns was dissected and stored at −80 ◦C. Protein
extraction was performed as previously described [14]. Briefly, epiphyseal cartilage was lysed using
TissueLyser II (QIAGEN, Hilden, Germany) and incubated with 100 µL 100 mM tris-acetate buffer,
pH 8.0, 10 mM EDTA, 0.1 U Chondroitinase ABC (Sigma-Aldrich, St. Louis, Missouri, USA) and
deglycosylated for 6 h at 37 ◦C. Protein extraction was performed with 500 µL chaotropic guanidine
buffer (4 M GuHCl, 65 mM DTT, 10 mM EDTA, 50 mM sodium acetate, pH 5.8) for 24 h at 4 ◦C.
Protein extracts were precipitated in 9 volumes of ice cold 96% (v/v) ethanol overnight at −20 ◦C,
washed twice with 70% (v/v) ethanol and resuspended in 8 M Urea, 50 mM triethyl ammonium
bicarbonate for proteome analysis or in 7 M urea, 2 M thiourea, 4% CHAPS, 30 mM Tris, pH 8.0 for
immunoblot analysis.
4.5. Proteome Analysis
Approximately 15 µg of protein/biological sample were sequentially reduced, alkylated, and
digested in Lys-C and trypsin using standard procedures. Peptide samples (n = 5 biological
replicates per genotype) were analyzed by liquid chromatography-MS on a Q Exactive Plus Orbitrap
(Thermo Fisher Scientific, Waltham, MA, USA) mass spectrometer coupled with an EASY nLC
1000 (Thermo Fisher Scientific, Waltham, MA, USA). The Orbitrap was operated in data-dependent
acquisition mode. Peptides were loaded onto an analytical column (self-packed, 50 cm–75 µm I.D.,
filled with 2.7 µm Poroshell EC120 C18, Agilent) using 0.1% formic acid as loading buffer. Peptides
were chromatographically separated with a gradient 3–5% 0.1% formic acid in 80% acetonitrile over
1 min and a constant flow rate of 250 nL/min, followed by 5–30% over 65 min, 30–50% over 13 min,
50–95% over 1 min, washing and column equilibration. The MS1 survey scan was acquired with a
resolving power set to 70,000 in the mass range from m/z 300 to m/z 1750. The top 10 most abundant
peptides were isolated within a 1.8 Th window and subjected to HCD fragmentation at normalized
collision energy of 27%. The AGC target was set to 5e5 charges, allowing a maximum injection time
of 55 ms. Product ions were detected in the Orbitrap at a resolution of 17,500. Precursors were
dynamically excluded for 15.0 s. Peptides were identified by searching expected protein sequences in
the UniProt Mouse database using MaxQuant software (version 1.5.3.8, https://www.maxquant.org/).
Standard settings were used (in short, 1% FDR using a reversed database with razor approach, LFQ
quantification and normalization using MaxLFQ algorithm [29] with activated match between runs
option between samples from the Cre control and hKO groups, respectively.
Afterwards, results from the protein group table were processed in Perseus (version 1.6.1.1,
https://www.maxquant.org/perseus). After initial basic data cleanup (removal of identifications
stemming from peptides only identified in modified form, or identified as contaminants, or from the
reverse database used for FDR calculations), all LFQ intensities were log2 transformed and samples
grouped together either in the Cre control or hKO group. All proteins not present in at least four
out of five replicates in at least one group were filtered out. Each sample was checked for normal
distribution of intensities before and after imputation of missing values, which was performed for
each sample individually. A two-sample Student’s t-test was performed with a permutation-based
FDR of 0.05, 250 randomizations, and an S0 of 0.2. Proteins with a resulting q-value below 0.05
(93 in total) were deemed significantly different between the two groups. The data were imported
in InstantClue (version 0.5.3, [30]) for visualization by principal component analysis, volcano plot
and hierarchical clustering. For volcano plot –log10 p-values were plotted against the log2 fold
change (a q-value < 0.05 was considered significant). Hierarchical cluster analysis was performed
with the log2 transformed LFQ intensities using the following settings: distant metrics—euclidean,
linkage rule—complete. Reactome analysis of significantly regulated proteins was performed using the
String database (http://string-db.or). Matrisome gene clusters, annotated in the matrisome database
2.0 (http://matrisomeproject.mit.edu) were imported in FunRich (version 3.1) to generate graphical
representations of altered core matrisome and matrisome associated proteins. The mass spectrometry
Int. J. Mol. Sci. 2020, 21, 4112 12 of 16
proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE [31] partner
repository with the dataset identifier PXD019374.
4.6. RNA Isolation and Semiquantitative PCR
Total RNA from frozen femoral and tibial epiphyseal cartilage of each animal was extracted
by phenol-chloroform extraction using TRIzol reagent (Thermo Fisher Scientific, Waltham, MA,
USA). The concentration of RNA was determined using NanoDrop 2000 spectrophotometer (Thermo
Fischer Scientific, Waltham, MA, USA). RNA was reversely transcribed into cDNA (Omniscript
RT assay, QIAGEN, Hilden, Germany) and 25 ng cDNA was used for REDTaq®® ReadyMix™
PCR assays (Sigma-Aldrich, St. Louis, MI, USA). The expression was normalized to ß-actin (Actb).
The following primers were used: Actb (forward: 5′-GACGAGGCCCAGAGCAAGAG-3′; reverse:
5′-CTAGAGCAACATAGCACAGC-3′) and Prg4 (forward: 5′-GTGGATGAAGCTGGAAGCGG-3′;
reverse: 5′-GTTGGAGGTGGTTCCTTGGG-3′.
4.7. Fluorescent In Situ Hybridization Analysis
Detection of Prg4 transcripts on cryotome sections (7 µm) was conducted using QuantiGene®®
ViewRNA ISH Tissue Assay Kit and QuantiGene®® ViewRNA ISH Cell Assay Kit (Affymetrix, Santa
Clara, CA, USA) according to the instruction of the manufacturer. An Alexa Fluor 488 (Affymetrix,
USA) labeled probe targeting nucleotides 2721–3891 of the murine transcript variant 1 (NM_021400.3,)
was used to detect PRG4 expression in situ. Stained sections were analyzed by immunofluorescence
microscopy (Nikon Eclipse TE2000-U Microscope, Nikon, Tokyo, Japan).
4.8. Immunoblot Analysis
Cartilage extracts (n ≥ 3 biological replicates per genotype) were incubated in SDS sample buffer
(62.5 mM Tris buffer, pH 6.8, 2% SDS, 10% glycerol, 0.04% bromophenol blue, 0.5% β-mercaptoethanol,
50 mM DTT) for 15 min at 65 ◦C, resolved on 8% SDS polyacrylamide gels and transferred onto
nitrocellulose (Whatman, Sigma-Aldrich, St. Louis, MI, USA). Primary antibodies against PRG4
(1/150, Invitrogen, Carlsbad, CA, USA), IBSP (1/500, Immundiagnostik, Bensheim, Germany), SOX6
(A4, 1/1000, Santa Cruz Biotechnology, Dallas, TX, USA), SOX9 (1/1000, Millipore, Burlington, MA, USA),
aggrecan (1/1000, Millipore, Burlington, Massachusetts, USA), collagen IX (1/2000, [32]), collagen II
(1/100, Abcam, Cambridge, UK), collagen X (X53, 1/500, [33]) and GAPDH (14C10, 1/1000, Cell Signaling
Technology, Danvers, MA, USA) were added overnight at 4 ◦C. Primary antibodies were detected by
corresponding secondary antibodies labeled with horseradish peroxidase (DAKO, Jena, Germany)
and visualized by enhanced chemoluminescence using 10 mM Tris, pH 8.8, 12.5 µM luminol, 2.3 µM
coumarin acid, 5.3 µM hydrogen peroxide solution. Band intensities were quantified by ImageJ
software [34]. A density profile line graph was obtained and the area under each peak was measured
as the number of pixels, normalized to GAPDH and calibrated by fixed point of control [35].
4.9. Gelatin Zymography
Femora extracts (n = 3 biological replicates per genotype) were lysed in 50 mM Tris buffer, pH 7.5,
150 mM NaCl, 1% (w/v) SDS, 0.5% (v/v) NP-40, mixed with non-reducing SDS sample buffer (62.5 mM
Tris buffer, pH 6.8, 2% (w/v) SDS, 10% (w/v) glycerol, 0.04% bromophenol blue) for 10 min at RT and
resolved on 8% SDS polyacrylamide gels copolymerized with 1 mg/mL gelatin (bovine skin type B,
Sigma-Aldrich, St. Louis, MI, USA) as previously described [36]. Gels were washed three times in 2.5%
(v/v) Triton X-100 for 20 min at RT to remove residual SDS and renaturate MMPs and then incubated in
50 mM Tris buffer, pH 7.4, 10 mM CaCl2, 0.02% (w/v) NaN3 for 3 h at 37 ◦C. Gels were stained with
Coomassie Blue R-250 and latent proMMP13 and active MMP13 gelatinase activity was detected as
clear bands against a blue background. The image was converted to 8 bit and band intensities were
quantified by ImageJ software [34].
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4.10. In Situ Zymography
Femora from newborn mice (n = 4 biological replicates per genotype) were isolated, embedded
in O.C.T. Tissue-Tek (Sakura Finetek, Tokyo, Japan) and sectioned using a Leica Cryotome CM3050.
Sections (7 µm) were washed three times in PBS and incubated with 20 µg/mL DQ gelatin (D-12054,
Invitrogen) in 50 mM Tris buffer, pH 7.6, 150 mM NaCl, 5 mM CaCl2, and 0.2 mM NaN3 overnight at
37 ◦C. To verify the contribution of matrix metallopeptidases, control slides were incubated with 20 mM
EDTA for 30 min at RT prior to addition of substrate containing 20 mM EDTA. Slides were incubated
for 10 min in the dark at RT in 4% paraformaldehyde, stained with DAPI, embedded in mounting
medium and analyzed by immunofluorescence microscopy (Nikon Eclipse TE2000-U Microscope,
Nikon, Tokyo, Japan).
4.11. Immunofluorescence Analysis
Femora from newborn mice (n = 4 biological replicates per genotype) were isolated, fixed in
4% paraformaldehyde overnight, embedded in paraffin and sectioned using a microtome (HM355 S,
ThermoFisher Scientific). Deparaffinized sections (7 µm) were digested with hyaluronidase (5 mg/mL)
for 30 min at 37 ◦C (Sigma-Aldrich, St. Louis, MI, USA), permeabilized with 0.25% TritonX-100 in
TBS for 10 min and incubated with 10% FCS and 5% normal goat serum blocking solution. Sections
were incubated with a primary MMP13-specific antibody (1/500, Abcam, Cambridge, UK) and the
corresponding secondary antibody coupled to Cy3 (Jackson ImmunoResearch, West Grove, PA,
USA) using standard protocols. Sections were embedded in mounting medium and analyzed by
immunofluorescence microscopy (Nikon Eclipse TE2000-U Microscope, Nikon, Tokyo, Japan).
4.12. Statistical Analysis
The Mann-Whitney-U-test was used to test for significance between two groups of samples (IBM
SPSS Statistics for Windows, version 26.0; Armonk, NY, USA: IBM Corp.). p-values of p < 0.05 (*) and
p < 0.01 (**) were considered as statistically significant. Mean values and standard deviations
are given (GraphPad Prism version 7.00 for Windows, GraphPad Software, La Jolla, CA, USA,
www.graphpad.com).
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Abbreviations
ACAN Aggrecan
ADAM A disintegrin and metalloproteinase
ADAMTS ADAM with thrombospondin motifs
COL Collagen
DMM Destabilization of the medial meniscus
DTT Dithiothreitol
ECM Extracellular matrix
EDTA Ethylenediaminetetraacetic acid
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EGTA Ethylene glycol-bis(β-aminoethyl ether)-N,N,N′,N′-tetraacetic acid
FC Fold change
FCS Fetal calf serum
GAPDH Glyceraldehyde 3-phosphate dehydrogenase
GuHCl Guanidinium hydrochloride
hKO Hemizygous knock-out
IBSP Bone sialoprotein 2
MDK Midkine
MgCl2 Magnesium chloride
miR, miRNA MicroRNA
MMP Matrix metallopeptidase
MS Mass spectrometry
OA Osteoarthritis
SDS Sodium dodecyl sulfate
SOX SRY-related HMG box-containing
TBS Tris-buffered saline
VTN Vitronectin
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